Hjem › Atopisk dermatitis (eczem) › Idaho
Atopisk dermatitis (eczem) kliniske forsøg i Idaho
4 studier for Atopisk dermatitis (eczem) søger deltagere på steder i Idaho.
Officiel studietekst (engelsk)
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Ada West Research - Meridian, Meridian
RekruttererFase 3
Alder 2 til 11 · Alle køn · Opdateret 25. sep. 2026 · NCT06807281A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Ada West Research, LLC, Meridian
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Treasure Valley Medical Research /ID# 266838, Boise
RekruttererFase 3
Alder 2 til 11 · Alle køn · Opdateret 6. aug. 2026 · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Treasure Valley Medical Research /ID# 263738, Boise
RekruttererFase 3
Alder 18 til 63 · Alle køn · Opdateret 6. jul. 2026 · NCT06389136Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.